Bazedoxifene acetate: a novel selective estrogen receptor modulator for the prevention and treatment of postmenopausal osteoporosis. [electronic resource]
- Drugs of today (Barcelona, Spain : 1998) Jul 2009
- 507-20 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1699-3993
10.1358/dot.2009.45.7.1395293 doi
Animals Clinical Trials as Topic Drug Evaluation, Preclinical Female Humans Indoles--adverse effects Osteoporosis, Postmenopausal--drug therapy Selective Estrogen Receptor Modulators--adverse effects